Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

TRPS1 is crucial for bone, kidney, and hair follicle development.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

TG5 helps maintain hair follicle health, while TG3 aids in hair shaft development.

Platelet-rich plasma speeds up bone healing and reduces complications.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

A treatment combining laser energy and injections improved hair loss and unexpectedly also reduced hair graying.

PT-20 did not significantly improve gray hair repigmentation.

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

Photothermal biomodulated PRP extends hair graft viability by 2 hours compared to standard solutions.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Early diagnosis and treatment of TPP can prevent complications.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Pueraria thunbergiana extract may help prevent hair from turning gray.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Transglutaminase 2 may control sebocyte maturation and lipid metabolism.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

PTHrP regulates various normal body functions, including bone development, skin, and muscle function.